Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-11-25
2000-01-25
Kemmerer, Elizabeth
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 530350, A61K 3817, C07K 14435
Patent
active
060178817
ABSTRACT:
The present invention provides methods of treating adverse physiological effects associated with intestinal ischemia/reperfusion by administering to a subject suffering from the effects of intestinal ischemia/reperfusion an effective amount of a BPI protein product.
REFERENCES:
patent: 5089274 (1992-02-01), Marra et al.
patent: 5153178 (1992-10-01), Maroko
patent: 5171739 (1992-12-01), Scott
patent: 5198541 (1993-03-01), Elsbach et al.
patent: 5234912 (1993-08-01), Marra et al.
patent: 5308834 (1994-05-01), Scott et al.
patent: 5334584 (1994-08-01), Scott et al.
patent: 5420019 (1995-05-01), Theofan et al.
Novotny et al. Evidence for lack of importance of oxygen free radicals in Escherichia coli endotoxemia in dogs. Am. J. Physiol., (May 1988) 254 (5 Pt 2) H954-62, Abstract only provided.
Goto et al. Adjuvant effects of beta-adrenergic drugs on indomethacin treatment of newborn canine endotoxic shock. J. Ped. Surgery (Oct. 1991) 26 (10) 1156-60, Abstract only provided.
Velkov z. Changes in rabbit cardiac function during fulminant endotoxin shock. Acta Physiol Pharmacol Bulg, (1994) 20 (1) 19-24, Abstract only provided.
Bone R C. Gram-negative sepsis. Background, clinical features, and intervention. Chest, (Sep. 1991) 100 (3) 802-8, Abstract only provided.
Caty et al. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury. Annals of Surgery, (Dec. 1990) 212 (6) 694-700.
Elsbach P; Weiss J. Bactericidal/permeability increasing protein and host defense against gram-negative bacteria and endotoxin. Current Opinion in Immunology, (Feb. 1993) 5 (1) 103-7.
Deitch EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Archives of Surgery vol. 125, Mar. 1990, 403-404.
Grace P A. Ischaemia-reperfusion injury. British Journal of Surgery, (May 1994) 81 (5) 637-47.
Ammons, et al., An N-Terminal Fragment Of Bactericidal/Permeability Increasing Protein (rBPI.sub.21) Reduces Cardiorespiratory Dysfunction Resulting From Intestinal Ischemia/Reperfusion, Annual Meeting of Professional Scientific Research Scientists, Experimental Biology 94.TM., Anaheim, California, Abstracts 1-3391, Part I, Ischemic Injury, 753 (Apr. 24-28, 1994).
Bahrami, et al., "Endotoxemia In Rats Subjected To The Haemorrhage. Effects Of Bactericidal/Permeability Increasing Protein (BPI)", Abstract Presented At Vienna International Endotoxin Society Meeting (Aug., 1992).
Bahrami, et al., "Bactericidal/Permeability-Increasing Protein (BPI) Reduces Lipopolysaccride (LPS)-Induced Cytokine Formation And Mortality In Rats," Circulatory Shock, Supplement 1, Abstract 12.25P, Vienna, Austria (May 9-13, 1993).
Boermeester, et al., "Peri-operative prophylaxis with bactericidal/permeability-increasing protein (rBPI.sub.23) prevents early postoperative derangements following partial hepatectomy," Intensive Care Medicine, vol. 20, Supplement 1, Abstract 478 (Mar., 1994).
Elsbach, et al., "Separation and Purification of a Potent Bactericidal/Permeability-increasing Protein and a Closely Associated Phospholipase A.sub.2 from Rabbit Polymorphonuclear Leukocytes," The Journal of Biological Chemistry, vol. 21, 11000-11009 (Nov. 10, 1979).
Gathiram, et al., "Changes in Lipopolysaccharide Concentrations in Hepatic Portal and Systemic Arterial Plasma During Intestinal Ischemia in Monkeys," Circulatory Shock, vol. 27, 103-109 (1989).
Gazzano-Santoro, et al., "High-Affinity Binding of the Bactericidal/Permeability-Increasing Protein and a Recombinant Amino-Terminal Fragment to the Lipid A Region of Lipopolysaccharide," Infection and Immunity, vol. 60, 4754-4761, (Nov., 1992).
Gray, et al., "Cloning of the cDNA of a Human Neutrophil Bactericidal Protein," The Journal of Biological Chemistry, vol. 264, No. 16, 9505-9509 (Jun., 1989).
Mainous, et al., "Bacterial Translocation," Pathophysiology of Shock, Sepsis, and Organ Failure, Springer-Verlag, 265-278 (1993).
Ooi, et al., "Endotoxin-neutralizing Properties of the 25kD N-Terminal Fragment and a Newly Isolated 30 kD C-Terminal Fragment of the 55-60 kD Bactericidal/Permeability-increasing Protein of Human Neutrophils," J. Exp. Med., vol. 174, 649-655 (Sep., 1991).
Weiss, et al., "Cellular and Subcellular Localization of the Bactericidal/Permeability-Increasing Protein of Neutrophils," Blood, vol. 69, No. 2, 652-659 (Feb., 1987).
Yao, et al., "Effects Of Bactericidal/Permeability Increasing Protein (BPI) Against Haemorrage-Induced Endotoxemia And Mortality In Rats," Intensive Care Medicine, vol. 20, Supplement 1, Abstract 479 (Mar., 1994).
Bone, Ann. Internal Med, 115(6): 457-469 (1991).
Glauser et al., Lancet, 338: 732-736 (1991).
Kilbourn et al., J. National Cancer Institute, 84(11): 827-831 (1992).
Natanson et al., Ann. Internal Med., 120(9): 771-783 (1994).
The Economist, "Panic in the Petri Dish," pp. 61-62 (Jul. 23, 1994).
Cross et al., Infect. Immun., 61: 2741-2747 (1993).
Petros et al., Lancet, 338: 1557-1558 (1991).
Bahrami et al., "Endotoxemia in Rats Subjected to the Haemorrhage: Effects of Bactericidal/Permeability Increasing Protein (BPI)," Int. Conf. on Endotoxins, Amsterdam, Aug. 17-20, 1993.
Little et al., "Functional Domains of Recombinant Bactericidal/Permeability Increasing Protein (rBPI.sub.23)," J. Biol. Chem., 269:1865-1872 (1994).
Von der Mohlen et al., "Effect of rBPI.sub.23 on Endotoxin-Induced Cytokine Release and Leukocyte Changes in Human Volunteers," Clinical Research Meeting, Apr. 29-May 2 1994.
Von der Mohlen et al., "Inhibition of Endotoxin-Induced Cytokine Release and Neutrophil Activation in Humans by Use of Recombinant Bactericidal/Permeability-Increasing Protein," J. Infect. Dis., 172:144-51 (1995).
Von der Mohlen et al., "Inhibition of Endotoxin-Induced Activation of the Coagulation and Fibrinolytic Pathways Using a Recombinant Endotoxin-Binding Protein (rBPI.sub.23)," Blood, 85:3437-3443 (1995).
Ammons William Steve
Meszaros Karoly M.
Kemmerer Elizabeth
Romeo David S.
Xoma Corporation
LandOfFree
Method of treating conditions associated with intestinal ischemi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating conditions associated with intestinal ischemi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating conditions associated with intestinal ischemi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2315966